Source comparison
Using TB-500 for Wound Healing Research Evidence: Model Comparison
| Injury Model | Species | TB-500 Dose | Closure Time Reduction vs Control | Collagen Organization Improvement | Translational Relevance to Human Healing | Professional Assessment ||—|—|—|—|—|—|| Full-thickness dermal excision | Mouse (C57BL/6) | 6mg/kg IP twi
This comparison does not assign a generated winner or score.
- | Injury Model | Species | TB-500 Dose | Closure Time Reduction vs Control | Collagen Organization Improvement | Translational Relevance to Human Healing | Professional Assessment ||—|—|—|—|—|—|| Full-thickness dermal excision | Mouse (C57BL/6) | 6mg/kg IP twice weekly | 42% faster closure (9.2 days vs 15.8 days) | 22% higher Type I:Type III collagen ratio | Moderate. Murine skin heals via contraction, not re-epithelialization like human skin | Strong preclinical signal but limited direct human relevance due to healing mechanism mismatch || Superficial digital flexor tendon injury | Horse | 7.5mg per week IM × 4 weeks | 34% greater fiber alignment at 12 weeks | 28% higher cross-sectional area, improved echogenicity scores | High. Equine tendon biomechanics and healing closely parallel human tendon injuries | Most clinically relevant animal model for soft tissue repair; direct applicability to human sports medicine research || Myocardial infarction (LAD ligation) | Rat (Sprague-Dawley)